Publicaciones (640) Publicaciones de MIGUEL ANGEL SANZ ALONSO

2024

  1. Cytomegalovirus Reactivations in Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Matched and Haploidentical Donors with Post-Transplantation Cyclophosphamide

    Transplantation and Cellular Therapy, Vol. 30, Núm. 5, pp. 538.e1-538.e10

  2. Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies

    Annals of Hematology

  3. Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience

    Annals of Hematology, Vol. 103, Núm. 2, pp. 451-461

  4. Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia

    Bone Marrow Transplantation

2023

  1. A global study for acute myeloid leukemia with RARG rearrangement

    Blood Advances, Vol. 7, Núm. 13, pp. 2972-2982

  2. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia

    British Journal of Haematology, Vol. 200, Núm. 2, pp. 170-174

  3. Disseminated toxoplasma infection after hematopoietic stem cell transplantation with myositis and encephalitis

    Transplant Infectious Disease

  4. Glomerulonephritis Secondary to Acute Promyelocytic Leukemia that Resolved after Induction Therapy

    Acta haematologica, Vol. 146, Núm. 3, pp. 240-244

  5. Impact of Post-Transplantation Cyclophosphamide on Transfusion Requirements in HLA-Matched Sibling Peripheral Blood Stem Cell Transplantation

    Transplantation and Cellular Therapy, Vol. 29, Núm. 5, pp. 313.e1-313.e10

  6. Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia

    Cancers, Vol. 15, Núm. 8

  7. Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia

    Blood Advances, Vol. 7, Núm. 1, pp. 167-173

  8. PCR-Based Strategy for Introducing CRISPR/Cas9 Machinery into Hematopoietic Cell Lines

    Cancers, Vol. 15, Núm. 17

  9. Reduced Incidence of Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation with Calcineurin-Free Graft-versus-Host Disease Prophylaxis

    Transplantation and Cellular Therapy, Vol. 29, Núm. 10, pp. 610.e1-610.e12

  10. T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia

    Transplantation and Cellular Therapy, Vol. 29, Núm. 5, pp. 322.e1-322.e5

  11. Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia

    British Journal of Haematology

  12. Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution

    Journal of Clinical Medicine, Vol. 12, Núm. 10

2022

  1. Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x)

    Nature Communications

  2. Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry

    Cancers, Vol. 14, Núm. 9

  3. Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia

    Cancers, Vol. 14, Núm. 11

  4. Healthcare Resource Utilization among Patients between 60–75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

    Cancers, Vol. 14, Núm. 8